An Australian randomized controlled trial of vitamin D products, conducted by the QIMR Berghofer Medical Research Institute has found that they do not protect most people from developing a cold, flu and other respiratory diseases.
The lawsuit, the largest of its kind to investigate the link between vitamin D and respiratory disease to date, showed that the medication could shorten the duration of the disease slightly and help by reducing the severity of these illnesses.
The results of the study were published this week in the scientific journal The Lancet Diabetes and Endocrinology.
The researchers analyzed self-reported health data from 16,000 Australians aged 60 to 84, who participated in the D-Health Test led by the QIMR Berghofer Medical Research Institute.
Lead researcher and head of QIMR Berghofer’s Aetology and Cancer Prevention group, Professor Rachel Neale, said participants who received vitamin D products reported experiencing cold and flu symptoms for a slightly shorter period of time. participants who did not take the vitamin. They also had very severe symptoms for less time and needed less medication to manage their symptoms.
Dr Neale said the results of the test are timely as people around the world are trying to understand how best to improve immunity against the Covid-19 pandemic.
“The D-Health Test was completed before the onset of Covid-19 pandemic disease so it does not provide specific answers about this. However, our conclusions are about length and severity.” as respiratory tract disease suggests that vitamin D supplementation may benefit the immune system, especially in people with a deficiency.
(Only the headline and image of this report may have been reworked by Industry Status staff; the rest of the content is automatically generated from syndicated feeds.)
Dear reader,
Business Standard has struggled to provide up-to-date information and reporting on developments that are of interest to you and have wider political and economic implications for the country and the world. Your constant encouragement and ideas on how we can improve our offer are just our solution and our commitment to making those ideas stronger. Even in those difficult times arising out of Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative comments and encouraging commentary on relevant issues.
We have a demand, though.
As we fight the economic impact of pandemic, we need your support even more, so that we can continue to offer you more quality content. Our membership module has seen an encouraging response from many of you, who have subscribed to our online content. More membership in our online content can help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through additional subscriptions can help us use the journalism we are committed to.
Support quality journalism and subscribe to Business Standards.
Digital editor